Vaccinations in Rheumatoid Arthritis

Eitan Giat, Merav Lidar

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Rheumatoid arthritis (RA) is the most prevalent chronic, inflammatory arthritides affecting the synovial membrane of multiple diarthrodial joints. Although its etiology has not been completely clarified, dysregulation of the immune system is evident with a preponderance of inflammatory cytokines and immune cells with joints. The risk of infection is increased in RA patients, due to both the inflammatory process and the immunosuppressive therapy administered for disease control. Vaccines are a powerful tool in the prevention of infectious disease, yet their safety and efficacy in RA patients differ from those in the healthy population as a result of their immune milieu. The general efficacy of vaccines is considered satisfactory in RA patients despite the attenuated immune response. Vaccines have sporadically been implicated as a trigger for the initiation of RA, although large epidemiological studies have not supported this association. Finally, vaccines are a potential tool in immune-modulation, and they are currently being tested as therapy for RA patients. In this review, we discuss the role of vaccines in RA etiology, the safety and efficacy of different vaccines in RA patients, and the possible future role of vaccines in RA therapy.

Original languageEnglish
Title of host publicationVaccines and Autoimmunity
PublisherWiley-Blackwell
Pages233-246
Number of pages14
ISBN (Electronic)9781118663721
ISBN (Print)9781118663431
DOIs
StatePublished - 1 Jan 2014

Keywords

  • European league against Rheumatism (EULAR)
  • Hepatitis B virus (HBV) vaccination
  • Rheumatoid arthritis (RA)
  • Varicella zoster virus (VZV)

Fingerprint

Dive into the research topics of 'Vaccinations in Rheumatoid Arthritis'. Together they form a unique fingerprint.

Cite this